What is Swell-light Biomodulation Technology (SLBM)?
What is Swell-light Biomodulation Technology (SLBM)?
The Dry Eye Therapy Device utilizes advanced Swell-light Biomodulation Technology (SLBM) combined with Photobiomodulation (PBM). Using red light (650nm) and near-infrared light (850nm), this non-invasive device targets the eye region to address Meibomian Gland Dysfunction (MGD), the primary cause of many dry eye symptoms. It improves tear film stability, reduces inflammation, and promotes overall eye health.
Why is Swell-light Biomodulation Technology important?
One of the key factors of dry eye syndrome is Meibomian Gland Dysfunction (MGD). MGD leads to inadequate lipid secretion in the tear film, causing excessive tear evaporation and ocular inflammation. SLBM technology addresses these concerns by:
- Improving lipid layer function: Heating the Meibomian glands to 35-38°C, dissolving and releasing blocked meibum.
- Reducing inflammation: Non-invasive light reduces eyelid inflammation and minimizes inflammatory mediators that degrade tear quality.
- Supporting tear film repair: Stimulates natural tear secretion and maintains tear film stability, alleviating dry eye symptoms.
Koushicare LuminEyes VS Other Treatments
